Company: HCWB
Filing Date: 2025-11-20
Form Type: 8-K
Source: 0001193125-25-289873
Chunk: 5

Company: HCW Biologics Inc.
Filing Date: 2025-11-20
Form: 8-K
Item: Item 9.01
Chunk 5
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

  Exhibit No.      Description                                                                   
 ─────────────────────────────────────────────────────────────────────────────────────────────────
          4.1      Form of New Warrant.                                                          
         10.1      Form of Inducement Agreement between the Company and Investor.                
         99.1      Press release dated November 19, 2025.                                        
          104      Cover Page Interactive Data File (embedded within the Inline XBRL document).  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                                             HCW Biologics Inc.                                 
  Date:      November 20, 2025      By:      /s/ Hing C. Wong                                   
                                             Hing C. Wong, Founder and Chief Executive Officer